跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPTIZOLINE EYE DROPS 0.05% - HSA Drug Approval Details
Approvals
/
HSA
/
OPTIZOLINE EYE DROPS 0.05%
Approved
THERAPEUTIC
OPTIZOLINE EYE DROPS 0.05%
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
🇸🇬 Health Sciences Authority
Approval Date
Mar 23, 1992
Approval ID
def3cd4f0b1b6e63
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Type
Therapeutic
Approval Details
Approval Id
def3cd4f0b1b6e63
Drug Name
OPTIZOLINE EYE DROPS 0.05%
Product Name
OPTIZOLINE EYE DROPS 0.05%
Approval Number
SIN06918P
Approval Date
1992-03-23
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SOLUTION
Route Of Administration
OPHTHALMIC
Atc Code
S01GA02
Atc Item Name
tetryzoline
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
TETRAHYDROZOLINE HCl
0.05%
TETRAHYDROZOLINE HCl
0.05%
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 23, 1992
Approval ID
def3cd4f0b1b6e63
Type
Therapeutic
Back to HSA Approvals